Ashurst and Perkins Coie have advised the underwriters on RIGOL Technologies Co., Ltd’s global offering and listing of H shares on the Main Board of The...
RIGOL Technologies Secures HK$1.14 Billion in Global Hong Kong IPO
Hanx Biopharmaceuticals Completes HK$586 Million Hong Kong IPO
Ashurst has advised ICBC International Capital Limited. Hanx Biopharmaceuticals (Wuhan) Co., Ltd., a China-based biopharmaceutical company, has successfully completed a global offering amounting to HK$586.3 million,...
Xizang Zhihui Mining Raises $550 Million in Hong Kong IPO
Ashurst has advised Xizang Zhihui Mining Co., Ltd. Xizang Zhihui Mining Co., Ltd. (SEHK: 2546) has completed a global offering and listed its shares on the...
HXPharma Completes HK$993.6 Million Hong Kong IPO
Ashurst has advised Fujian Haixi Pharmaceutical Co., Ltd. (HXPharma). Fujian Haixi Pharmaceutical Co., Ltd. (HXPharma) has successfully completed its global offering of shares and listing on...
Butong Group Completes HK$781.84 Million Hong Kong IPO
Ashurst has advised the underwriters of Butong Group. Butong Group has completed its global offering and successfully listed its shares on the Main Board of The...
Cloudbreak Pharma Launches Successful IPO on Hong Kong Stock Exchange
Ashurst has advised the joint sponsors and underwriters on Cloudbreak Pharma’s global offering and Hong Kong listing. Cloudbreak Pharma Inc., a clinical-stage biotechnology company, successfully completed...
Shandong Boan Biotechnology’s HK$400 Million H Shares Placement
Ashurst has advised UBS AG Hong Kong Branch on the deal. Shandong Boan Biotechnology Co., Ltd. has successfully completed the placing of 38,400,000 new H shares...
Newtrend Group Completes Hong Kong IPO
Ashurst has advised Newtrend Group Holding Co., Ltd. on the deal. Newtrend Group Holding Co., Ltd., a leading Chinese manufacturer of food-grade glycine and sucralose, has...
Shanghai Voicecomm Information Technology’s US$85 Million Initial Public Offering
Ashurst acted as the U.S. counsel to Shanghai Voicecomm Information Technology, while O’Melveny represented the underwriters on the offering. Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK)...
NSSK III Series Funds’ ¥105 Billion
Simpson Thacher & Bartlett advised Nippon Sangyo Suishin Kiko on the deal. Nippon Sangyo Suishin Kiko (“NSSK”) announced the NSSK III Series Fund that closed with aggregate capital...
Mercuria’s ¥43.85 Billion Formation of Mercuria II Series Funds
Simpson Thacher & Bartlett advised Mercuria Investment Co., Ltd. on the fund formation. Mercuria Investment Co., Ltd. announced the formation of the Mercuria II Series Funds, which...
PAG’s $1.8 Billion PREP III Formation
Simpson Thacher & Bartlett advised PAG Real Assets in the deal. PAG Real Assets announced the formation and fundraising of PAG Real Estate Partners III (PREP III),...